Advanced Primary Peritoneal Carcinoma

DrugDrug NameDrug Description
DB11793NiraparibA poly-ADP ribose polymerase inhibitor used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy.
DB09074OlaparibA poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.
DrugDrug NamePhaseStatusCount
DB11740Adavosertib0Active Not Recruiting1
DB18028Azenosertib0Withdrawn1
DB00062Albumin human1Recruiting1
DB11595Atezolizumab1Recruiting1
DB08875Cabozantinib1Recruiting1
DB00441Gemcitabine1Active Not Recruiting1
DB01229Paclitaxel1Recruiting1
DB00531Cyclophosphamide1 / 2Active Not Recruiting1
DB01262Decitabine1 / 2Active Not Recruiting1
DB17107Lifileucel1 / 2Active Not Recruiting1